Monte Rosa Therapeutics, Inc.

GLUE

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001193125-26-094296
Filing date: Mar 5, 2026
Earliest execution date: Mar 4, 2026
Reporting Owners: Dunn Edmund (Principal Accounting Officer)
SEC Filing link

Summary

Type

Sell

Net shares

-139

% of shares

-0.61%

Amount (USD)

$2,496

Insider confidence score

50.0 out of 100

Positive

  • Tax withholding obligation
  • Minimal sell amount (<$10K)

Negative

  • Moderate tax withholding sell (≥0.5% of shares)

Stock transactions

Transaction 1

Security

Common Stock

Action

Sell

Date

2026-03-04

Code

S

Net shares

-139.0

Price per Share

$17.96

Amount (USD)

$2,496.44

Acquired/Disposed

Disposed

Shares Owned Before

22,693.0

Shares Owned After

22,554.0

Filing's footnotes

1. Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person.

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.